- Home
- JCSE vs PALI Comparison
JCSE vs PALI Comparison
Compare JCSE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- PALI
- Stock Information
- Founded
- JCSE 1999
- PALI 1996
- Country
- JCSE Singapore
- PALI United States
- Employees
- JCSE N/A
- PALI N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JCSE Consumer Discretionary
- PALI Health Care
- Exchange
- JCSE Nasdaq
- PALI Nasdaq
- Market Cap
- JCSE 5.9M
- PALI 5.0M
- IPO Year
- JCSE 2022
- PALI N/A
- Fundamental
- Price
- JCSE $0.90
- PALI $0.80
- Analyst Decision
- JCSE
- PALI Strong Buy
- Analyst Count
- JCSE 0
- PALI 2
- Target Price
- JCSE N/A
- PALI $12.00
- AVG Volume (30 Days)
- JCSE 10.5K
- PALI 6.2M
- Earning Date
- JCSE 05-15-2025
- PALI 08-11-2025
- Dividend Yield
- JCSE 9.99%
- PALI N/A
- EPS Growth
- JCSE N/A
- PALI N/A
- EPS
- JCSE 0.00
- PALI N/A
- Revenue
- JCSE $14,126,397.00
- PALI N/A
- Revenue This Year
- JCSE N/A
- PALI N/A
- Revenue Next Year
- JCSE N/A
- PALI N/A
- P/E Ratio
- JCSE $195.99
- PALI N/A
- Revenue Growth
- JCSE 6.92
- PALI N/A
- 52 Week Low
- JCSE $0.86
- PALI $0.60
- 52 Week High
- JCSE $2.39
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- JCSE 34.60
- PALI 44.16
- Support Level
- JCSE $1.04
- PALI $0.66
- Resistance Level
- JCSE $1.00
- PALI $1.90
- Average True Range (ATR)
- JCSE 0.04
- PALI 0.17
- MACD
- JCSE -0.01
- PALI -0.03
- Stochastic Oscillator
- JCSE 0.00
- PALI 11.37
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.